# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Prader-Willi syndrome

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 24 results.
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
Status: Recruiting
Last Changed: Feb 28, 2020
First Received: Aug 28, 2018
Disease(s): Prader-Willi Syndrome
Intervention(s): intranasal carbetocin Dose 1, intranasal carbetocin Dose 2, placebo
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
Phoenix Children's Hospital, Phoenix, Arizona, United States
Children's Hospital of Los Angeles (USC), Los Angeles, California, United States
Stanford Children's Health, Palo Alto, California, United States
Rady Children's Hospital San Diego, San Diego, California, United States
... and 25 other locations.
CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
Status: Not yet recruiting
Last Changed: Mar 04, 2020
First Received: Feb 20, 2019
Disease(s): Prader-Willi Syndrome
Intervention(s): CBDV Compound, Placebo
Locations: Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States
Open-Label Extension Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
Status: Recruiting
Last Changed: Jan 29, 2020
First Received: Oct 22, 2018
Disease(s): Prader-Willi Syndrome
Intervention(s): DCCR
Locations: Stanford University, Palo Alto, California, United States
Rady Children's Hospital San Diego, San Diego, California, United States
Children's Hospital Colorado, Aurora, Colorado, United States
University of Florida Gainesville, Gainesville, Florida, United States
Emory Children's Center, Atlanta, Georgia, United States
... and 15 other locations.
Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory
Status: Recruiting
Last Changed: Feb 27, 2019
First Received: Apr 05, 2017
Disease(s): Prader-Willi Syndrome
Intervention(s): Listening Project Protocol
Locations: Latham Centers School, Brewster, Massachusetts, United States
A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
Status: Not yet recruiting
Last Changed: Feb 10, 2020
First Received: Feb 06, 2020
Disease(s): Prader-Willi Syndrome
Intervention(s): Pitolisant oral tablets, Placebo oral tablet
Register of Patients With Prader-Willi Syndrome
Status: Recruiting
Last Changed: Apr 26, 2019
First Received: Jul 12, 2016
Disease(s): Prader-Willi Syndrome
Intervention(s): Data collection
Locations: University Hospital of Children, Toulouse, France
Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome
Status: Not yet recruiting
Last Changed: Aug 28, 2019
First Received: Aug 26, 2019
Disease(s): Prader-Willi Syndrome
Intervention(s): Placebo, Guanfacine extended release (GXR)
Locations: NYU Langone Health, New York, New York, United States
Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
Status: Recruiting
Last Changed: Mar 24, 2020
First Received: Jan 02, 2019
Disease(s): Prader-Willi Syndrome, Hyperphagia
Intervention(s): Livoletide, Placebo
Locations: University of Alabama at Birmingham, Birmingham, Alabama, United States
University of California - Irvine Medical Center, Orange, California, United States
Rady Children's Hospital - San Diego, San Diego, California, United States
Children's Hospital Colorado, Denver, Colorado, United States
University of Kansas Medical Center, Kansas City, Kansas, United States
... and 34 other locations.
An Open-Label Study of DCCR Tablet in Patients With PWS
Status: Not yet recruiting
Last Changed: Sep 12, 2019
First Received: Sep 12, 2019
Disease(s): Prader-Willi Syndrome
Intervention(s): DCCR
Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years
Status: Recruiting
Last Changed: Dec 03, 2018
First Received: Apr 14, 2017
Disease(s): Prader-Willi Syndrome
Intervention(s): Oxytocin, Placebo, Oxytocin
Locations: Centre de référence du syndrome de Prader-Willi Hôpital des Enfants, Toulouse, France